陳曉鈴Hsiao-Ling Chen陳怡娟Yi-chuan Chen營養科學研究所2026-03-242002-10-282002https://handle.ncl.edu.tw/11296/f754xthttps://scholars.csmu.edu.tw/handle/123456789/6669本實驗探討22位第二型糖尿病合併高血脂患者(糖尿病組,Fasting blood glucose, FBG<180 mg/dl, Total cholesterol, TC &sup3; 200 mg/dl)與21位血糖正常血脂正常(健康組FBG < 100 mg/dl0 , TC <200 mg/dl)年齡介於50 - 75歲的受測者,其飲食習慣、飲食內容、固定運動習慣、營養攝取量等問卷表及血液生化值的差異,並利用蒟蒻(Amorphophallus Konjac)的塊根萃取蒟蒻精粉(glucomannan,GM)為實驗材料,探討GM補充劑介入對糖尿病組的受測者其飯前血糖(FBG)、餐後2小時血糖(2h postprandial)、糖化血色素(HbA1C)、血液尿素氮(BUN)、三酸甘油脂(Triglyceride, TG)、總膽固醇(TC)、高密度脂蛋白膽固醇(HDL-cholesterol, HDL-C) 、低密度脂蛋白膽固醇(LDL-cholesterol, LDL-C)、總膽固醇/高密度脂蛋白膽固醇比值(TC/HDL-C) 紅血球(RBC)、血色素(Hemoglobin)、血球容積(Hematocrit)、血小板(Platelet)、血球平均數值(MCV)、血液尿素氮(BUN)、尿酸(Uric acid)、肌酐酸(Creatinine)、總蛋白質(Total Protein)、白蛋白(Albumin)、膽紅素(Bilirubin)、GOT轉胺酵素及GPT轉胺酵素之影響。 由問卷表的結果發現糖尿病組的受測者中其教育程度(不識字及小學以下佔68.1%)低於健康組的受測者(高中以上學歷佔61%)、糖尿病組的受測者大部份曾有胃腸道方面的疾病(胃疾病32﹪,習慣性便秘36﹪,習慣性腹瀉41﹪)高於健康組的受測者,大部份的健康組受測者有補充營養補充劑(48%)的習慣,而糖尿病組的受測者除了醫院所開的藥物外沒有人額外補充任何營養補充劑、糖尿病組的受測者血液生化值中空腹血糖值FBS (p < 0.001)及HbA1c (p <0.01)、TG (p <0.01)、TC (p < 0.01)、LDL-C (p < 0.01)、 TC/HDL-C (p<0.01)明顯的高於健康組,兩組受測者其血壓、脈搏、體重、BMI、飲食特性、固定運動習慣及營養狀況並無明顯的差異。第二型糖尿病合併高血脂患者在控制期與蒟蒻期時的營養素、熱量、體重、BMI血壓、脈搏及其他血液生化值則無顯著差異,給予GM補充劑介入 4週後,發現GM補充劑可有效降低餐前血糖19.75% (p <0.01)、餐後2小時血糖下降18.41% ( p < 0.01)、餐後血糖變化30.79 % (p < 0.01)、TG 下降12.99% (p < 0.04)、TC 下降9.75% (p < 0.03)、LDL-C下降13.31% (p < 0.03) 、LDL-C/HDL-C脂蛋白比值下降14.28% (p < 0.04)及LDL-C/HDL-C下降 14.28 % (p < 0.01)。 由此實驗歸納得知GM對第二型糖尿病合併高血脂患者血糖的控制及降低血脂濃度有很好的效應,服用GM補充劑期間除了排便及排氣的頻率增加外並不會影響體內其他血液生化值的變化及有不適的症狀出現。 關鍵字:蒟蒻、糖尿病、交叉雙盲實驗模式、血糖、血脂The main goal of the present study was to compare the nutritional profile of healthy and diabetic adults ranging from 50-75 yo. Secondly, effects of konjac glucomannan (KGM)supplement (3.6 g/d)for 28 d on blood glucose and lipid levels in hyperlipidemic type 2 diabetic patients were examined in this double-blind, crossover trial. Subjects were recruited through local advertisement or. Twenty-one healthy adults (age 60.6±5.3, BMI 23.3±3.7 kg/m2) were recruited from the local advertisement for the evaluation of nutritional status. On the other hand, twenty-two diabetic subjects (fasting blood glucose < 180 mg/dL, age 65.3±8.8 years, BMI 25.5±3.15 kg/m2) with elevated blood cholesterol levels ( &sup3;200 mg/dL) were recruited from the outpatient department of the General Veterinarian Hospital. Fasting blood samples were drawn for plasma lipids, fasting glucose, 2-h postprandial glucose and HbA1C levels, and other nutritional indices for each experimental period. Results: The levels of education, gastrointestinal problems, and chewing difficulty were higher in the diabetic subjects than the healthy counterpart. The KGM supplement effectively reduced concentrations of serum fasting glucose (P<0.01) and postprandial glucose ( P<0.05), triglyceride ( P<0.01), cholesterol ( P<0.01), LDL-cholesterol (P<0.03), and the total/HDL cholesterol ratio (P<0.04), as compared with the changes caused by placebo, respectively. Serum HDL-cholesterol, HbA1C, and other biochemical indices were not affected by the KGM treatment. KGM supplement did not affect the body weight, and blood pressure, either. However, the defecation frequency was significantly increased with the KGM supplementation. The KGM supplement improved blood lipid levels and alleviated the elevated glucose levels without gastroinstestinal side effects in diabetic subjects. Therefore, KGM could be an adjunct for the treatment of hyperlipidemic diabetic subjects.蒟蒻糖尿病交叉雙盲實驗模式血糖血脂konjac glucomannandiabetic mellitusdouble-blindcrossover trialblood sugarblood lipid蒟蒻補充劑對第二型糖尿病患之血脂、血糖及營養狀況影響之探討thesis